Rachel Wang: ADCs and the Hidden Immune Landscape After Tumor Cell Death
4h agoen
Source
OncoDailyRachel Wang: ADCs and the Hidden Immune Landscape After Tumor Cell Deathoncodaily.comRachel Wang, Founder and Principal Consultant at Polaris BioStrategy, shared a post on LinkedIn: “ADCs are built to kill tumor cells. My immunologist brain keeps asking a different question: what […]
You might also wanna read
Explainable machine learning-guided integrated multiomics analysis reveals macrophage-driven immune suppression in breast cancer
doi.org·12d ago
Alp Bio's AI platform predicts immune reactions to biologic drugs earlier in development
An interview with Christian Vahlensieck, co-founder of Alp Bio, a Swiss startup using an AI-powered platform combined with lab-grown human i
vist.ly·12d ago
Alp Bio's AI platform predicts immune reactions to biologic drugs in early development
An interview with Christian Vahlensieck, co-founder of Alp Bio, a Swiss startup using an AI-powered platform combined with lab-grown human i
vist.ly·15d ago
Tumor-on-a-Chip Reveals How Pancreatic Cancer Hijacks Immune Cells
Medbound·17h ago
ETS1 Identified as Dual Driver of Metastasis and Immune Evasion in Squamous Cell Carcinoma
This study identifies the transcription factor ETS1 as a master regulator of a hybrid epithelial-mesenchymal transition (hEMT) program in up
aacrjournals.org·1mo ago
Nanoplatform co-delivering H2S and Ni2+ reverses chemoresistance and enhances immunotherapy in breast cancer
This research article presents a study on a novel nanoplatform (NiS@ALB) designed to combat chemoresistance in breast cancer. The authors de
cell.com·1d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.